课题基金 / 基金详情

The mechanism of immune insufficiency against retroviral tumors and its restoration

The mechanism of immune insufficiency against retroviral tumors and its restoration
逆转录病毒肿瘤免疫功能低下的机制及其修复
批准号:
15023217
负责人:
KANNAGI Mari
金额:
$10.94万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

KANNAGI Mari的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
It has been noted that adult T-cell leukemia (ATL) is incidentally associated with mother-to-child infection, mostly established via mother milk. In our rat system, orally infected rats exhibited significantly higher levels of persistent human T-cell leukemia virus type I (HTLV-I) load and much weaker immune response to HTLV-I than that in intraperitoneally infected rats. As a result, persistent viral load was inversely correlated with levels of virus-specific T-cell responses. The insufficient immune responses in orally infected rats could be, however, recovered by subcutaneous re-immunization with appropriate antigens. We also investigated cellular immune responses of ATL patients who obtained complete remission following non-myeloablative allogeneic peripheral blood hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling donors, and found that HTLV-I Tax-specific CTL response was strongly activated in some of these patients post-HSCT but not before HSCT. These findings suggest that HTLV-I-specific immune insufficiency established at primary HTLV-I infection may be an underlying risk factor for development of ATL, but could be overcome with immunological strategies.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
H.Liu, T.Ohashi, T.Masuda.X.Zhou, M.Kubo, M.Kannagi: "Suppression of HIV-I replication by HIV-I-irrelevant CD8+ cytotoxic T lymphocytes resulting in preservation of persistently HIV-I-infected cells in vitro."Viral Immunology. 16. 381-393 (2003)
H.Liu、T.Ohashi、T.Masuda.X.Zhou、M.Kubo、M.Kannagi:“通过与 HIV-1 无关的 CD8 细胞毒性 T 淋巴细胞抑制 HIV-1 复制,导致持续保存 HIV-1-
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1002/ijc.20737
发表时间: 2005-03-20
期刊: INTERNATIONAL JOURNAL OF CANCER
影响因子: 6.4
作者: [Kurihara, K, Harashima, N, Kannagi, M]
通讯作者: Kannagi, M
Future prophylaxis and immunotherapy for adult T cell leukemia.
成人 T 细胞白血病的未来预防和免疫治疗。
DOI: --
发表时间: 2004
期刊: Expert Review of Anticancer Therapy 4
影响因子: --
作者: [M.Kannagi, et al.]
通讯作者: et al.
Correlation of major hi stocompatibi1ity complex class I downregulation with resistance of human T cell leukemia virus type I-infected T cells to cytotoxic T-lymphocyte killing in a rat model.
在大鼠模型中,主要组织相容性复合体 I 类下调与人 T 细胞白血病病毒 I 型感染的 T 细胞对细胞毒性 T 淋巴细胞杀伤的抵抗力的相关性。
DOI: --
发表时间: 2002
期刊: J.Virol. 76
影响因子: --
作者: [T.Ohashi, S.Hanabuchi, R.Suzuki, H.Kato, H.Tateno, T.Masuda, M.Kannagi.]
通讯作者: M.Kannagi.
15
    Host innate immune mechanisms separating inflammatory or lymphoproliferative diseases in HTLV-1 infection
    Anti-viral immuno therapeutic approaches for adult T-cell leukemia
    • 批准号:
      17013028
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $31.04万
    • 财政年份:
      2005
    • 负责人:
      KANNAGI Mari
    • 依托单位:
    Role of vertical transmission of HTLV-I on the risk for T cell malignancy
    • 批准号:
      12470052
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.91万
    • 财政年份:
      2000
    • 负责人:
      KANNAGI Mari
    • 依托单位:
    Spontaneous inhibition of HTL V-I expression in the peripheral blood
    海外基金